The use of Real-World Data (RWD) by Health Technology Assessment (HTA) agencies

被引：0
|
作者：
Karen, K.
机构：
来源：
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2021年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：218 / 218
页数：1
相关论文
共 50 条
  • [1] Using real-world data (RWD) in health technology assessment (HTA) practice: A comparative study of 5 HTA agencies
    Makady, Amr
    van Veelen, Ard
    Jonsson, Pall
    Moseley, Owen
    D'Andon, Anne
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 91 - 91
  • [2] USING REAL-WORLD DATA (RWD) IN HEALTH TECHNOLOGY ASSESSMENT (HTA) PRACTICE: A COMPARATIVE STUDY OF 5 HTA AGENCIES
    Makady, A.
    van Veelen, A.
    Jonsson, P.
    Moseley, O.
    D'Andon, A.
    de Boer, A.
    Hillege, J. L.
    Klungel, O.
    Goettsch, W.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A401 - A401
  • [3] Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
    Makady, Amr
    ten Ham, Renske
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    [J]. VALUE IN HEALTH, 2017, 20 (04) : 520 - 532
  • [4] POLICIES FOR USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT: A COMPARATIVE STUDY OF 6 HTA AGENCIES
    Makady, A.
    ten Ham, R.
    de Boer, A.
    Hillege, J. L.
    Klungel, O.
    Goettsch, W.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A501 - A502
  • [5] Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
    Amr Makady
    Ard van Veelen
    Páll Jonsson
    Owen Moseley
    Anne D’Andon
    Anthonius de Boer
    Hans Hillege
    Olaf Klungel
    Wim Goettsch
    [J]. PharmacoEconomics, 2018, 36 : 359 - 368
  • [6] Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies
    Makady, Amr
    van Veelen, Ard
    Jonsson, Pall
    Moseley, Owen
    D'Andon, Anne
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    [J]. PHARMACOECONOMICS, 2018, 36 (03) : 359 - 368
  • [7] Policy and practice: the role Real-World Data (RWD) in Health Technology Assessment
    de Waure, Chiara
    Petelos, Elena
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 : 217 - 217
  • [8] COMPARISON OF THE USE OF REAL-WORLD EVIDENCE (RWE) BY HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES IN REVIEWS OF DRUGS FOR RARE DISEASES (DRDS)
    Kirby, J.
    Tadros, N.
    Gosain, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S508 - S508
  • [9] A REVIEW OF REAL-WORLD EVIDENCE IN NON-ONCOLOGY SUBMISSIONS MADE TO FOUR HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES
    Balijepalli, C.
    Li, J.
    Ferrazzi, S.
    Mathers, E.
    Gullapalli, L.
    Awan, A.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S253 - S254
  • [10] A COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE POST-REIMBURSEMENT COLLECTION OF REAL-WORLD DATA (RWD) IN ONCOLOGY APPRAISALS ISSUED BY SIX HTA AGENCIES
    Gurjar, K.
    Harricharan, S.
    Nguyen, K.
    Forsythe, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S239 - S239
12345